Closed
Japan Entry Acceleration Program 2025 (JEAP 2025)
Incubator & Accelerator
Event
About
The Japan Entry Acceleration Program 2025 (JEAP 2025) offers startups in the regenerative medicine and gene therapy sectors a unique opportunity to accelerate their entry into the Japanese market through comprehensive support, including market insights, expert guidance, and a Demo Day to showcase their innovations to potential partners and investors, all at no cost to participants.
Benefits
- 💰Financial SupportFree participation
- 🎓Training & MentorshipOnline workshops to understand the Japanese market and prepare for collaboration opportunities
- 🎓Training & MentorshipOnline mentoring and business guidance
- 🤝Networking OpportunitiesMatching meetings with Japanese CDMO/CRO and pharmaceutical companies
- 🎤Publicity OpportunitiesDemo Day to showcase project results to Japanese businesses, investors, and ecosystem partners
Eligibility Criteria
- Startups focused on regenerative medicine, cell therapy, gene therapy, and advanced therapy medicinal products (ATMPs)
- Companies with confirmed clinical development candidates
- Companies interested in entering the Japanese market
- Commitment to participate in multiple online meetings and events
- Ability to attend the Demo Day in Japan and assist with promotional activities
Target Sector
Regenerative Medicine and Gene Therapy
Target Location
Global
Want to discover more opportunities like this?
Join StartupLinkX for free and get matched with relevant funding, competitions, grants, and more.
Found an issue with this listing?
Japan External Trade Organization (JETRO)